No Data
No Data
Retail Investors Among Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Largest Stockholders and Were Hit After Last Week's 12% Price Drop
Dr. Glasses: 2024 Semi-Annual Report
Dr. Glasses: 2024 Semi-Annual Report Summary
Doctorglasses chain (300622.SZ): The net income in the first half of the year was 52.3847 million yuan, with a proposed dividend of 1.6 yuan per 10 shares.
Doctorglasses (300622.SZ) announced its semi-annual report for 2024, with operating revenue of 0.601 billion yuan, a YoY growth of 0.34%; net income attributable to shareholders of the listed company was 52.3847 million yuan, a YoY decrease of 21.31%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 45.8677 million yuan, a YoY decrease of 26.79%; basic earnings per share was -0.16 yuan; a cash dividend of 1.60 yuan (including tax) is proposed to be distributed to all shareholders for every 10 shares.
Doctorglasses Chain Co.,Ltd.'s (SZSE:300622) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Yidao Information (001314.SZ): Currently, there is no cooperation with doctorglasses chain.
On August 13th, Gelunhui reported that Yidao Information (001314.SZ) stated on the investor interaction platform that its subsidiary, Yijing Virtual, focuses on development and delivery services of XR products for near-eye display, 3D spatial display, and spatial calculation. It is a mature provider of products, solutions, and technologies with the ability to mass produce products in the XR industry. Among them, AR glasses, as an important branch of XR products, have served many well-known AR clients for Yijing. The company is steadily developing its new product, AI glasses, which will be launched this year. Stay tuned for updates. The company currently has no cooperation with doctorglasses chain and there is no information on this matter in the future.
No Data
No Data